RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Overview Fund Activity
Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

144 hedge funds and large institutions have $1.94B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
+28
Holders Change %
+24.14%
% of All Funds
2.49%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
46
Increased
51
Reduced
30
Closed
18
Calls
$38.7M
Puts
$41.4M
Net Calls
-$2.68M
Net Calls Change
+$9.9M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$68.7M
2
State Street
2
State Street
Massachusetts
$93.6M
3
FAM
3
Fred Alger Management
New York
$61.1M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$92.2M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$18.9M

Top Sellers

1
WP
1
Woodline Partners
California
$16.4M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$35M
3
EAM
3
Eventide Asset Management
Massachusetts
$158M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
SI
5
Sofinnova Investments
California
$8.25M
Name Holding Trade Value Shares
Change 		Shares
Change %
GTCM
151
Gyon Technologies Capital Management
New Jersey
– -$805K -28,532 Closed
UOC
152
UBS O'Connor
Illinois
– -$678K -24,000 Closed
GCM
153
Graham Capital Management
Connecticut
– -$657K -23,294 Closed
JF
154
Jump Financial
Illinois
– -$542K -19,200 Closed
Simplex Trading
155
Simplex Trading
Illinois
– -$323K -11,448 Closed
Jane Street
156
Jane Street
New York
– -$294K -10,416 Closed
DTL
157
Dynamic Technology Lab
Singapore
– -$230K -8,130 Closed
QT
158
Quantbot Technologies
New York
– -$145K -5,158 Closed
3 4 5 6
7